Free Trial

Celldex Therapeutics (CLDX) Competitors

Celldex Therapeutics logo
$20.21 -0.16 (-0.77%)
As of 02:27 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

CLDX vs. IONS, ALKS, BCRX, LGND, FOLD, MNKD, NVAX, DVAX, INVA, and OPK

Should you be buying Celldex Therapeutics stock or one of its competitors? The main competitors of Celldex Therapeutics include Ionis Pharmaceuticals (IONS), Alkermes (ALKS), BioCryst Pharmaceuticals (BCRX), Ligand Pharmaceuticals (LGND), Amicus Therapeutics (FOLD), MannKind (MNKD), Novavax (NVAX), Dynavax Technologies (DVAX), Innoviva (INVA), and OPKO Health (OPK). These companies are all part of the "biotechnology" industry.

Celldex Therapeutics vs.

Celldex Therapeutics (NASDAQ:CLDX) and Ionis Pharmaceuticals (NASDAQ:IONS) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, profitability, earnings, risk, media sentiment, valuation, community ranking, dividends and analyst recommendations.

93.9% of Ionis Pharmaceuticals shares are held by institutional investors. 3.8% of Celldex Therapeutics shares are held by insiders. Comparatively, 2.6% of Ionis Pharmaceuticals shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Ionis Pharmaceuticals has a net margin of -64.25% compared to Celldex Therapeutics' net margin of -1,544.32%. Celldex Therapeutics' return on equity of -19.75% beat Ionis Pharmaceuticals' return on equity.

Company Net Margins Return on Equity Return on Assets
Celldex Therapeutics-1,544.32% -19.75% -18.86%
Ionis Pharmaceuticals -64.25%-100.05%-15.70%

Celldex Therapeutics has a beta of 1.39, meaning that its stock price is 39% more volatile than the S&P 500. Comparatively, Ionis Pharmaceuticals has a beta of 0.15, meaning that its stock price is 85% less volatile than the S&P 500.

Ionis Pharmaceuticals received 81 more outperform votes than Celldex Therapeutics when rated by MarketBeat users. However, 75.27% of users gave Celldex Therapeutics an outperform vote while only 60.46% of users gave Ionis Pharmaceuticals an outperform vote.

CompanyUnderperformOutperform
Celldex TherapeuticsOutperform Votes
627
75.27%
Underperform Votes
206
24.73%
Ionis PharmaceuticalsOutperform Votes
708
60.46%
Underperform Votes
463
39.54%

Celldex Therapeutics currently has a consensus target price of $53.90, indicating a potential upside of 166.24%. Ionis Pharmaceuticals has a consensus target price of $56.67, indicating a potential upside of 72.56%. Given Celldex Therapeutics' stronger consensus rating and higher probable upside, equities analysts clearly believe Celldex Therapeutics is more favorable than Ionis Pharmaceuticals.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Celldex Therapeutics
0 Sell rating(s)
2 Hold rating(s)
7 Buy rating(s)
1 Strong Buy rating(s)
2.90
Ionis Pharmaceuticals
1 Sell rating(s)
6 Hold rating(s)
12 Buy rating(s)
1 Strong Buy rating(s)
2.65

Celldex Therapeutics has higher earnings, but lower revenue than Ionis Pharmaceuticals. Ionis Pharmaceuticals is trading at a lower price-to-earnings ratio than Celldex Therapeutics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Celldex Therapeutics$7.56M177.79-$141.43M-$2.70-7.50
Ionis Pharmaceuticals$717.25M7.29-$366.29M-$2.99-10.98

In the previous week, Celldex Therapeutics and Celldex Therapeutics both had 12 articles in the media. Celldex Therapeutics' average media sentiment score of 1.66 beat Ionis Pharmaceuticals' score of 1.12 indicating that Celldex Therapeutics is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Celldex Therapeutics
11 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive
Ionis Pharmaceuticals
8 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Celldex Therapeutics beats Ionis Pharmaceuticals on 11 of the 17 factors compared between the two stocks.

Get Celldex Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for CLDX and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CLDX vs. The Competition

MetricCelldex TherapeuticsDiagnostic substances IndustryMedical SectorNASDAQ Exchange
Market Cap$1.34B$2.59B$5.31B$8.31B
Dividend YieldN/A0.73%5.20%4.10%
P/E Ratio-7.887.3926.6919.58
Price / Sales177.7935.72393.58120.51
Price / CashN/A15.7538.2534.62
Price / Book2.235.436.744.47
Net Income-$141.43M-$65.73M$3.23B$248.32M
7 Day Performance-1.00%-1.00%0.01%-1.26%
1 Month Performance4.19%-0.36%8.69%10.52%
1 Year Performance-44.26%-16.87%18.36%8.53%

Celldex Therapeutics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CLDX
Celldex Therapeutics
1.9643 of 5 stars
$20.21
-0.8%
$53.90
+166.6%
-46.5%$1.34B$7.56M-7.87150Gap Up
IONS
Ionis Pharmaceuticals
4.4031 of 5 stars
$34.03
+1.4%
$56.67
+66.5%
-12.5%$5.42B$717.25M-11.19800Positive News
Analyst Forecast
ALKS
Alkermes
4.6166 of 5 stars
$31.45
+0.1%
$38.33
+21.9%
+24.1%$5.19B$1.51B14.492,280Positive News
BCRX
BioCryst Pharmaceuticals
4.6077 of 5 stars
$10.37
+1.3%
$16.56
+59.6%
+56.0%$2.17B$503.49M-17.00530Positive News
Analyst Upgrade
LGND
Ligand Pharmaceuticals
4.3412 of 5 stars
$105.31
+0.7%
$146.14
+38.8%
+16.1%$2.03B$181.49M41.9680Positive News
FOLD
Amicus Therapeutics
3.9764 of 5 stars
$6.42
-0.2%
$16.22
+152.7%
-35.6%$1.98B$543.14M-35.67480Positive News
High Trading Volume
MNKD
MannKind
2.9208 of 5 stars
$4.47
+2.3%
$10.00
+123.7%
-12.4%$1.36B$297.60M63.86400Positive News
NVAX
Novavax
3.7108 of 5 stars
$7.74
+15.0%
$19.00
+145.5%
-53.6%$1.25B$1.21B-3.421,990Gap Down
High Trading Volume
DVAX
Dynavax Technologies
4.2284 of 5 stars
$9.83
+1.7%
$24.00
+144.2%
-17.3%$1.18B$294.62M54.61350
INVA
Innoviva
4.326 of 5 stars
$18.63
+0.3%
$55.00
+195.2%
+17.0%$1.17B$369.84M27.00100Positive News
OPK
OPKO Health
4.3132 of 5 stars
$1.33
flat
$2.75
+106.8%
-3.8%$1.05B$689.41M-7.004,200

Related Companies and Tools


This page (NASDAQ:CLDX) was last updated on 5/23/2025 by MarketBeat.com Staff
From Our Partners